YOLANDA COCKERHAM: Open Payments
NPI 1003066606 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,442 in 166 payments from 15 companies in 2025. Trend: 2023 $1,984 · 2024 $3,217 · 2025 $3,442
Food & beverage: $3,330Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 26 | $735 |
| Janssen Pharmaceuticals, Inc | 27 | $460 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $430 |
| Teva Pharmaceuticals USA, Inc. | 8 | $320 |
| ABBVIE INC. | 23 | $313 |
| Axsome Therapeutics, Inc. | 6 | $236 |
| E.R. Squibb & Sons, L.L.C. | 12 | $199 |
| Alkermes, Inc. | 8 | $185 |
| Lundbeck LLC | 16 | $172 |
| Otsuka America Pharmaceutical, Inc. | 10 | $153 |
Products named: INGREZZA, CAPLYTA, SPRAVATO, VRAYLAR, Auvelity, COBENFY, REXULTI, UZEDY.
Industry payments across LA — which companies pay providers there.
